Humanized anti - BAG... 申请号：JP2018522955 专利类型：发明申请 公开（公告）日：2016-11-02
状态：寻求转化 转让价格：面议
The present invention provides for a humanized anti-BAG3 antibody or a fragment thereof. pharmaceutical compositions comprising said antibody and its use as a medicament, in particular for use in the...
Human papillomavirus... 申请号：JP2018563450 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Methods and compositions for constructing and producing recombinant adenovirus-based vector vaccines are provided. In particular aspects, there are be provided compositions and methods involving aden...
Human immunodeficien... 申请号：JP2016525875 专利类型：发明授权 公开（公告）日：2014-10-23
状态：寻求转化 转让价格：面议
Compounds of Formula I with activity against HIV, including pharmaceutical compositions and methods for using these compounds in treating human immunodeficiency virus (HIV) infection, are set forth ...
Human cells used med... 申请号：JP2014541421 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
This disclosure provides the first description of hESC-derived cells transplanted into human patients. Results are reported for one patient with each of Stargardt' s Macular Dystrophy (SMD) and Dry Ag...
Human antibodies aga... 申请号：JP2018531184 专利类型：发明申请 公开（公告）日：2016-12-15
状态：寻求转化 转让价格：面议
The present invention provides caninized human anti-human IL-4Rα antibodies that have specific sequences and a high binding affinity for canine IL-4Rα. The invention also relates to use of these antib...
Human antibodies aga... 申请号：JP2016542318 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to the combination therapy of specific antibodies which human CSF-1R with specific antibodies which bind human PD-L1.
Human anti-IL-a 32 a... 申请号：JP2016522617 专利类型：发明授权 公开（公告）日：2014-07-03
状态：寻求转化 转让价格：面议
Provided are novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies as well as IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutica...
Human anti-FGFR4 [..... 申请号：JP2018534691 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to the medical use of antibodies against the FGF receptor 4 (FGFR4) combined with Sorafenib, in particular for the prevention or treatment of hyperproliferative diseases...
Hub and remote cellu... 申请号：US08705012 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention discloses a hub and remote cellular system having RF generating equipment located at a centralized hub, and RF front end equipment located at each of a plurality of remote omni-...
HuTNFR 1 is the inte... 申请号：KR1020187031138 专利类型：发明申请 公开（公告）日：2017-04-04
状态：寻求转化 转让价格：面议
The invention provides for an inhibitor of the huTNFRI receptor which is a human or humanized antibody construct that monovalently recognizes huTNFRI through an antigen-binding moiety, which is chara...
